|
IT1199374B
(it)
*
|
1984-05-15 |
1988-12-30 |
Alfa Farmaceutici Spa |
Processo per la preparazione di pirido-imidazo-rifamicine
|
|
IT1264494B1
(it)
*
|
1993-03-23 |
1996-09-24 |
Alfa Wassermann Spa |
Uso di rifaximin e di formulazioni che la contengono nel trattamento delle dispepsie gastriche originate da helicobacter
|
|
US6861053B1
(en)
*
|
1999-08-11 |
2005-03-01 |
Cedars-Sinai Medical Center |
Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
|
|
US7048906B2
(en)
|
1995-05-17 |
2006-05-23 |
Cedars-Sinai Medical Center |
Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
|
|
US5981522A
(en)
*
|
1995-09-01 |
1999-11-09 |
Kaneka Corporation |
Treatment of disease caused by infection of Helicobacter
|
|
ES2237809T3
(es)
*
|
1997-02-28 |
2005-08-01 |
Kaneka Corporation |
Medicina curativa para la enfermedad causada por infeccion de helicobacter.
|
|
US7122525B2
(en)
*
|
2001-11-21 |
2006-10-17 |
Activbiotics, Inc. |
Targeted therapeutics and uses thereof
|
|
AU2002364162A1
(en)
*
|
2001-12-13 |
2003-06-30 |
Activbiotics, Inc. |
Sulfhydryl rifamycins and uses thereof
|
|
ATE552824T1
(de)
*
|
2002-11-05 |
2012-04-15 |
Fadim S R L |
Kontrollierte und kontinuierliche verabreichung von rifaximin
|
|
US7820652B2
(en)
*
|
2003-09-24 |
2010-10-26 |
Activbiotics Pharma, Llc |
Regimen for the administration of rifamycin-class antibiotics
|
|
US7906542B2
(en)
*
|
2004-11-04 |
2011-03-15 |
Alfa Wassermann, S.P.A. |
Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin
|
|
ITMI20032144A1
(it)
*
|
2003-11-07 |
2005-05-08 |
Alfa Wassermann Spa |
Forme polimorfe di rifaximina, processi per ottenerle e
|
|
US7902206B2
(en)
*
|
2003-11-07 |
2011-03-08 |
Alfa Wassermann, S.P.A. |
Polymorphic forms α, β and γ of rifaximin
|
|
US7923553B2
(en)
*
|
2003-11-07 |
2011-04-12 |
Alfa Wassermann, S.P.A. |
Processes for the production of polymorphic forms of rifaximin
|
|
US20080262024A1
(en)
*
|
2003-11-07 |
2008-10-23 |
Giuseppe Claudio Viscomi |
Rifaximin compositions and method of use
|
|
US7265107B2
(en)
*
|
2004-03-10 |
2007-09-04 |
Cumbre Pharmaceuticals Inc. |
Rifamycin C-11 oxime cyclo derivatives effective against drug-resistant microbes
|
|
US7256187B2
(en)
*
|
2004-03-10 |
2007-08-14 |
Cumbre Pharmaceuticals Inc. |
Rifamycin C-11 oxime derivatives effective against drug-resistant microbes
|
|
US7202246B2
(en)
*
|
2004-06-09 |
2007-04-10 |
Cumbre Pharmaceuticals Inc. |
Spiro-rifamycin derivatives targeting RNA polymerase
|
|
US8003118B2
(en)
*
|
2005-03-02 |
2011-08-23 |
Kodsi Robert E |
Use of rifaximin for the prevention of aspiration pneumonia and/or sepsis
|
|
US20060210483A1
(en)
*
|
2005-03-02 |
2006-09-21 |
Kodsi Robert E |
Non-systemic antibiotic formulations and related method of use and treatment of upper respiratory infections
|
|
US20060210492A1
(en)
*
|
2005-03-02 |
2006-09-21 |
Kodsi Robert E |
Use of rifaximin for treatment and prevention of periodontal conditions
|
|
SI1698630T1
(sl)
*
|
2005-03-03 |
2015-01-30 |
Alfa Wassermann S.P.A. |
Nove polimorfne oblike rifaksimina, postopki za njihovo pripravo in njihova uporaba v medicinskih pripravkih
|
|
ITBO20050123A1
(it)
|
2005-03-07 |
2005-06-06 |
Alfa Wassermann Spa |
Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
|
|
JP5368092B2
(ja)
|
2005-08-11 |
2013-12-18 |
ターガンタ セラピュティクス，インコーポレイティド |
ホスホン化リファマイシン類および骨と関節感染の予防と治療のためのその投与法
|
|
DK1996710T3
(da)
|
2006-03-09 |
2019-10-07 |
Salix Pharmaceuticals Inc |
Rifaximin-præparat mod rektal dysfunktion
|
|
JP5844961B2
(ja)
|
2006-08-02 |
2016-01-20 |
サリックス ファーマシューティカルズ， インコーポレイテッド |
放射線直腸ｓ状結腸炎を処置するための組成物および方法
|
|
ITMI20061692A1
(it)
|
2006-09-05 |
2008-03-06 |
Alfa Wassermann Spa |
Uso di polioli per ottenere forme polimorfe stabili di rifaximina
|
|
KR101667534B1
(ko)
*
|
2006-09-22 |
2016-10-19 |
씨아이피엘에이 엘티디. |
리팍시민
|
|
US20080161337A1
(en)
*
|
2007-01-03 |
2008-07-03 |
Leonard Weinstock |
Use of Rifaximin for the Treatment of Chronic Prostatitis
|
|
US20080159987A1
(en)
*
|
2007-01-03 |
2008-07-03 |
Leonard Weinstock |
Use of Rifaximin for the Treatment of Restless Legs Syndrome
|
|
ITMI20071241A1
(it)
*
|
2007-06-20 |
2008-12-21 |
Solmag S P A |
Processo per la preparazione di rifaximina amorfa e rifaximina amorfa cosi' ottenuta
|
|
ES2389358T5
(es)
|
2007-07-06 |
2016-01-19 |
Lupin Ltd. |
Composiciones farmacéuticas de rifaximina
|
|
JP5755878B2
(ja)
|
2007-07-06 |
2015-07-29 |
ルパン リミテッドＬｕｐｉｎ Ｌｉｍｉｔｅｄ |
リファキシミンの薬剤組成物
|
|
US7709634B2
(en)
*
|
2007-09-20 |
2010-05-04 |
Apotex Pharmachem Inc. |
Amorphous form of rifaximin and processes for its preparation
|
|
SG10201607926VA
(en)
*
|
2008-02-25 |
2016-11-29 |
Salix Pharmaceuticals Ltd |
Forms of rifaximin and uses thereof
|
|
US8486956B2
(en)
|
2008-02-25 |
2013-07-16 |
Salix Pharmaceuticals, Ltd |
Forms of rifaximin and uses thereof
|
|
US20110065741A1
(en)
|
2009-02-26 |
2011-03-17 |
Salix Pharmaceuticals, Ltd. |
Methods for treating irritable bowel syndrome (ibs)
|
|
US11779571B2
(en)
|
2008-02-26 |
2023-10-10 |
Salix Pharmaceuticals, Inc. |
Methods for treating irritable bowel syndrome (IBS)
|
|
KR20100122937A
(ko)
|
2008-02-26 |
2010-11-23 |
샐릭스 파마슈티컬스 리미티드 |
장 질환의 치료 방법
|
|
WO2009137672A1
(en)
|
2008-05-07 |
2009-11-12 |
Salix Pharmaceuticals, Ltd. |
Methods of treating bowel disease by administering a bowel cleanser and an antibiotic
|
|
WO2010019511A2
(en)
|
2008-08-13 |
2010-02-18 |
Targanta Therapeutics Corp. |
Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections
|
|
US8980872B2
(en)
|
2008-09-26 |
2015-03-17 |
Aska Pharmaceutical Co., Ltd. |
Agent for preventing and/or treating functional gastrointestinal disorder
|
|
HUE065491T2
(hu)
|
2008-10-02 |
2024-05-28 |
Salix Pharmaceuticals Ltd |
A hepatikus enkefalopátia kezelése rifaximin alkalmazásával
|
|
ES2718614T3
(es)
|
2008-12-10 |
2019-07-03 |
Cipla Ltd |
Complejos de rifaximina
|
|
IT1397617B1
(it)
*
|
2009-04-20 |
2013-01-18 |
Alfa Wassermann Spa |
Nuovi derivati della rifamicina
|
|
WO2011005388A1
(en)
|
2009-06-02 |
2011-01-13 |
Salix Pharmaceuticals, Ltd. |
Methods of treating hepatic encephalopathy
|
|
NZ599944A
(en)
|
2009-10-27 |
2015-10-30 |
Lupin Ltd |
Solid dispersion of rifaximin
|
|
CA2781580A1
(en)
|
2009-11-23 |
2011-05-26 |
Cipla Limited |
Topical foam composition
|
|
WO2011080691A1
(en)
|
2009-12-28 |
2011-07-07 |
Silvio Massimo Lavagna |
Method for the production of amorphous rifaximin
|
|
CA2789929C
(en)
|
2010-02-18 |
2019-11-26 |
Salix Pharmaceuticals, Ltd. |
Methods for treating infection
|
|
IT1398550B1
(it)
|
2010-03-05 |
2013-03-01 |
Alfa Wassermann Spa |
Formulazioni comprendenti rifaximina utili per ottenere un effetto prolungato nel tempo
|
|
CA2800235C
(en)
|
2010-03-10 |
2018-10-16 |
Lupin Limited |
Rifaximin ready-to-use suspension
|
|
ES2801678T3
(es)
|
2010-07-12 |
2021-01-12 |
Salix Pharmaceuticals Inc |
Formulaciones de rifaximina y sus usos
|
|
US8759513B2
(en)
|
2010-09-13 |
2014-06-24 |
Sequent Scientific Limited |
Polymorphic form of rifaximin and process for its preparation
|
|
US8735419B2
(en)
|
2011-02-11 |
2014-05-27 |
Salix Pharmaceuticals, Ltd. |
Forms of rifaximin and uses thereof
|
|
EP2705042A1
(en)
|
2011-05-02 |
2014-03-12 |
Ranbaxy Laboratories Limited |
Rifaximin dimethylformamide solvate
|
|
ITMI20110890A1
(it)
|
2011-05-19 |
2012-11-20 |
A M S A Anonima Materie Sint & Affini S P A |
Polimorfo di rifaximina e processo per la sua preparazione
|
|
ITBO20110461A1
(it)
|
2011-07-29 |
2013-01-30 |
Alfa Wassermann Spa |
Composizioni farmaceutiche comprendenti rifaximina, processi per la loro preparazione e loro uso nel trattamento di infezioni vaginali.
|
|
RU2496475C2
(ru)
|
2011-10-26 |
2013-10-27 |
Александр Васильевич Иващенко |
Фармацевтическая композиция и набор для лечения бактериальных инфекций
|
|
PL2773205T3
(pl)
|
2011-11-02 |
2024-09-02 |
Salix Pharmaceuticals, Inc. |
Ryfaksymina w leczeniu ustępującej biegunki z przewagą zespołu jelita drażliwego
|
|
WO2013112809A2
(en)
*
|
2012-01-25 |
2013-08-01 |
Salix Pharmaceuticals, Ltd |
Rifaximin derivative and uses thereof
|
|
ITBO20120368A1
(it)
|
2012-07-06 |
2014-01-07 |
Alfa Wassermann Spa |
Composizioni comprendenti rifaximina e amminoacidi, cristalli di rifaximina derivanti da tali composizioni e loro uso.
|
|
WO2014091432A1
(en)
|
2012-12-12 |
2014-06-19 |
Ranbaxy Laboratories Limited |
Pharmaceutical compositions of rifaximin
|
|
MX2015011802A
(es)
|
2013-03-15 |
2016-01-08 |
Alfa Wassermann Spa |
Rifaximina para usarse en el tratamiento de infecciones vaginales.
|
|
US20160047819A1
(en)
|
2013-03-15 |
2016-02-18 |
Alfa Wassermann S.P.A. |
Method for diagnosing vaginal infections
|
|
PL2983647T3
(pl)
|
2013-04-12 |
2021-01-25 |
Alfasigma S.P.A. |
Podawanie nlpz oraz związane z tym składniki, sposoby i układy
|
|
US9018225B1
(en)
|
2013-07-26 |
2015-04-28 |
Novel Laboratories |
Rifaximin crystalline forms and methods of preparation thereof
|
|
EP2927235B1
(en)
|
2014-03-31 |
2017-02-08 |
Euticals S.P.A. |
Polymorphic mixture of rifaximin and its use for the preparation of solid formulations
|
|
EP3134415A4
(en)
*
|
2014-04-19 |
2017-10-25 |
Granules India Limited |
An improved process for the preparation of rifamycin derivatives
|
|
CN106795192B
(zh)
|
2014-05-04 |
2020-06-16 |
萨利克斯药品公司 |
Ibs微生物群及其用途
|
|
WO2015173697A1
(en)
|
2014-05-12 |
2015-11-19 |
Alfa Wassermann S.P.A. |
New solvated crystal form of rifaximin, production, compositions and uses thereof
|
|
EP2982764A1
(en)
|
2014-08-05 |
2016-02-10 |
ALFA WASSERMANN S.p.A. |
Identification of vaginal bacteria
|
|
US9988398B2
(en)
|
2016-06-07 |
2018-06-05 |
Cadila Healthcare Limited |
Crystalline form of rifaximin and process for its preparation
|
|
EP3518924B1
(en)
|
2016-09-30 |
2022-08-10 |
Salix Pharmaceuticals, Inc. |
Solid dispersion forms of rifaximin
|
|
ES2868180T3
(es)
*
|
2017-06-26 |
2021-10-21 |
Biofer Spa |
Derivados de pirido-imidazo rifamicina como agentes antibacterianos
|
|
IT201700091912A1
(it)
*
|
2017-08-08 |
2019-02-08 |
Biofer Spa |
Nuove pirido-imidazo rifamicine
|